SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-21-008149
Filing Date
2021-02-24
Accepted
2021-02-24 16:49:57
Documents
103
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vtvt-10k_20201231.htm 10-K 2792193
2 EX-4.3 vtvt-ex43_13.htm EX-4.3 21263
3 EX-10.35 vtvt-ex1035_391.htm EX-10.35 404188
4 EX-10.36 vtvt-ex1036_390.htm EX-10.36 71170
5 EX-21.1 vtvt-ex211_9.htm EX-21.1 2947
6 EX-23.1 vtvt-ex231_14.htm EX-23.1 9537
7 EX-31.1 vtvt-ex311_8.htm EX-31.1 17714
8 EX-31.2 vtvt-ex312_6.htm EX-31.2 17778
9 EX-32.1 vtvt-ex321_7.htm EX-32.1 7514
10 EX-32.2 vtvt-ex322_12.htm EX-32.2 7366
11 GRAPHIC gvpy4clnswxw000001.jpg GRAPHIC 153403
  Complete submission text file 0001564590-21-008149.txt   10899916

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT vtvt-20201231.xml EX-101.INS 2068224
13 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20201231.xsd EX-101.SCH 88933
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20201231_cal.xml EX-101.CAL 64374
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20201231_def.xml EX-101.DEF 349585
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20201231_lab.xml EX-101.LAB 614108
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20201231_pre.xml EX-101.PRE 500502
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37524 | Film No.: 21674192
SIC: 2834 Pharmaceutical Preparations